At Antleron, we're committed to advancing personalized medicine, which is why we've teamed up with Tuatara DX, pioneers in molecular diagnostic technologies. Together, we are revolutionizing healthcare by translating their cutting-edge solutions into a point-of-need test. Leveraging Antleron's expertise in microfluidics, we're developing an innovative test card where DNA mutation detection will occur seamlessly.
Through our collaborative effort in the Point-of-Need-Diagnostics (PoN-DX) project, we're dedicated to providing a game-changing solution in healthcare. Our goal is to accelerate the accurate detection of illnesses and identification of appropriate treatments, ultimately reducing side effects and hospital admissions.
This project is a testament to the power of cross-border collaborations, made possible with the support of CrossRoads Flanders-Netherlands. To learn more about PoN-DX, check out a short article (in Dutch) by CrossRoads -> https://interregvlaned.eu/nieuws/sneltest-voor-behandeling-op-maat
Point-of-Need-Diagnostics is funded by the European Union.
Comments